12/17/12 09:53 | 12/14/12 | AUXL | Health | Drug | Pharmaceutical Preparations | Adams Adrian | PA | DO | CEO,P | P | 0 | 0.00 | 0 | 56 | 999% | 57 | D | | | | | | | | | | | | | | |
3/1/12 17:01 | 2/28/12 | AUXL | Health | Drug | Pharmaceutical Preparations | Brandt Peter C. | PA | D | | P | 201 | 20.10 | 8 | 10 | New | 10 | D | -36 | -12 | 12 | 17 | -2 | -3 | -1 | -2 | 1 | -2 | | | | |
11/7/11 17:05 | 11/3/11 | AUXL | Health | Drug | Pharmaceutical Preparations | Fickenscher James E | PA | O | CFO | P | 25 | 15.54 | 12 | 2 | 6 | 27 | D | -55 | -30 | -33 | 7 | 6 | -7 | -9 | 0 | 3 | 0 | 16 | 32 | | |
3/31/11 18:01 | 3/30/11 | AUXL | Health | Drug | Pharmaceutical Preparations | 14159 Capital (Gp), LLC | NY | T | | P | 86 | 21.98 | 16 | 4 | 3 | 150 | I | -21 | -29 | -12 | 4 | -1 | -5 | 0 | 0 | 0 | -3 | 13 | -8 | -31 | |
3/31/11 17:59 | 3/30/11 | AUXL | Health | Drug | Pharmaceutical Preparations | Baker Bros. Capital (Gp), LLC | NY | T | | P | 7 | 21.98 | 16 | 0 | 5 | 7 | I | -21 | -29 | -12 | 4 | -1 | -5 | 0 | 0 | 0 | -3 | 13 | -8 | -31 | |
3/31/11 17:50 | 3/29/11 | AUXL | Health | Drug | Pharmaceutical Preparations | Baker Brothers Life Sciences Capital (Gp), LLC | NY | T | | P | 7,298 | 21.98 | 16 | 332 | 6 | 6,105 | I | -21 | -29 | -12 | 4 | -1 | -5 | 0 | 0 | 0 | -3 | 13 | -8 | -31 | |
3/10/11 20:04 | 3/8/11 | AUXL | Health | Drug | Pharmaceutical Preparations | 14159 Capital (Gp), LLC | NY | T | | P | 130 | 22.86 | 12 | 6 | 4 | 146 | I | -14 | -29 | -13 | 21 | 3 | 7 | 6 | 4 | 4 | -2 | -9 | -7 | -26 | -14 |
3/10/11 20:03 | 3/8/11 | AUXL | Health | Drug | Pharmaceutical Preparations | Baker Brothers Life Sciences Capital (Gp), LLC | NY | T | | P.m | 22,640 | 22.90 | 12 | 988 | 21 | 5,773 | I | -14 | -29 | -13 | 21 | 3 | 7 | 6 | 4 | 4 | -2 | -9 | -7 | -26 | -14 |
8/30/10 16:47 | 8/26/10 | AUXL | Health | Drug | Pharmaceutical Preparations | 14159 Capital (Gp), LLC | NY | T | | P.m | 78 | 25.51 | 14 | 3 | 2 | 140 | I | -34 | -8 | -16 | -9 | 16 | 0 | 4 | 7 | 1 | 7 | 1 | -23 | -12 | -32 |
8/30/10 16:45 | 8/26/10 | AUXL | Health | Drug | Pharmaceutical Preparations | Baker Brothers Life Sciences Capital (Gp), LLC | NY | T | | P.m | 2,820 | 25.51 | 14 | 111 | 2 | 4,785 | I | -34 | -8 | -16 | -9 | 16 | 0 | 4 | 7 | 1 | 7 | 1 | -23 | -12 | -32 |
3/11/10 19:19 | 3/9/10 | AUXL | Health | Drug | Pharmaceutical Preparations | 14159 Capital (Gp), LLC | NY | T | | P.m | 164 | 32.92 | 23 | 5 | 4 | 137 | I | 29 | 21 | 6 | 0 | 16 | 7 | 8 | 8 | 0 | -8 | -4 | -26 | -21 | -32 |
3/11/10 19:15 | 3/9/10 | AUXL | Health | Drug | Pharmaceutical Preparations | Baker Brothers Life Sciences Capital (Gp), LLC | NY | T | | P.m | 4,231 | 32.47 | 23 | 130 | 3 | 4,674 | I | 29 | 21 | 6 | 0 | 16 | 7 | 8 | 8 | 0 | -8 | -4 | -26 | -21 | -32 |
5/10/07 13:10 | 5/8/07 | AUXL | Health | Drug | Pharmaceutical Preparations | Fickenscher James E | PA | O | CFO | P | 20 | 13.38 | 3 | 2 | 4 | 37 | D | 178 | 92 | 7 | 0 | 2 | -12 | -6 | 5 | -3 | 1 | 11 | 56 | 89 | 112 |
3/14/06 16:31 | 3/10/06 | AUXL | Health | Drug | Pharmaceutical Preparations | Kessig Edward F | PA | O | VP,Sales | P | 23 | 6.43 | 1 | 4 | New | 4 | | | | | | | | | | 1 | 12 | 31 | 50 | 42 | 103 |
3/14/06 16:18 | 3/10/06 | AUXL | Health | Drug | Pharmaceutical Preparations | Fickenscher James E | PA | O | CFO | P | 6 | 6.43 | 1 | 1 | 3 | 32 | | | | | | | | | | 1 | 12 | 31 | 50 | 42 | 103 |
3/14/06 16:16 | 3/10/06 | AUXL | Health | Drug | Pharmaceutical Preparations | Henwood Geraldine | PA | DO | CEO | P | 6 | 6.43 | 1 | 1 | 0 | 257 | | | | | | | | | | 1 | 12 | 31 | 50 | 42 | 103 |
11/30/05 12:38 | 11/28/05 | AUXL | Health | Drug | Pharmaceutical Preparations | Stacey Jennifer Evans | PA | O | EVP,GC | P | 27 | 5.31 | 0 | 5 | New | 5 | D | | -43 | 17 | -12 | 11 | 19 | 11 | 3 | 5 | 19 | 4 | 36 | 65 | 211 |
11/23/05 16:14 | 11/22/05 | AUXL | Health | Drug | Pharmaceutical Preparations | Classon Rolf A | PA | D | | P | 25 | 5.09 | 0 | 5 | New | 5 | D | | -44 | 6 | -14 | 8 | 31 | 27 | 11 | 4 | 8 | 12 | 45 | 60 | 217 |
11/14/05 09:56 | 11/11/05 | AUXL | Health | Drug | Pharmaceutical Preparations | Fickenscher James E | PA | O | CFO | P | 21 | 4.24 | 0 | 5 | New | 5 | D | | -51 | -16 | -39 | -19 | -8 | 3 | -6 | 10 | 15 | 45 | 74 | 99 | 301 |
7/8/05 16:14 | 6/30/05 | AUXL | Health | Drug | Pharmaceutical Preparations | Churchill Winston J | PA | DT | | P.a | 4,969 | 4.90 | 0 | 1,014 | 31 | 4,270 | M | | | -44 | -12 | 4 | 4 | 0 | 4 | 6 | 14 | 25 | -15 | 2 | 46 |
7/5/05 17:46 | 6/30/05 | AUXL | Health | Drug | Pharmaceutical Preparations | Perseus Soros Biopharmaceutical Fund LP | NY | T | | P.d | 2,999 | 4.90 | 0 | 612 | 19 | 3,877 | D | | | -46 | -18 | -1 | -4 | -1 | -2 | -1 | 23 | 42 | 1 | 11 | 65 |
7/5/05 17:37 | 6/30/05 | AUXL | Health | Drug | Pharmaceutical Preparations | Scp Private Equity Partners II LP | PA | T | | P.d | 3,239 | 4.90 | 0 | 661 | 22 | 3,688 | D | | | -46 | -18 | -1 | -4 | -1 | -2 | -1 | 23 | 42 | 1 | 11 | 65 |
7/5/05 17:36 | 6/30/05 | AUXL | Health | Drug | Pharmaceutical Preparations | Churchill Winston J | PA | DT | | P.d | 4,969 | 4.90 | 0 | 1,014 | 31 | 4,270 | M | | | -46 | -18 | -1 | -4 | -1 | -2 | -1 | 23 | 42 | 1 | 11 | 65 |
7/5/05 15:55 | 6/30/05 | AUXL | Health | Drug | Pharmaceutical Preparations | Credit Suisse/ | | T | | P.d | 5,908 | 4.90 | 0 | 1,206 | 52 | 3,508 | I | | | -46 | -18 | -1 | -4 | -1 | -2 | 3 | 26 | 46 | 4 | 15 | 68 |
9/2/04 16:49 | 7/28/04 | AUXL | Health | Drug | Pharmaceutical Preparations | Churchill Winston J | PA | DT | | P.ad | 375 | 7.50 | 0 | 50 | 2 | 3,027 | I | | | | | | -4 | 3 | 2 | 5 | 5 | 15 | 13 | -32 | -33 |
8/2/04 20:46 | 7/28/04 | AUXL | Health | Drug | Pharmaceutical Preparations | Credit Suisse First Boston/ | NY | T | | P.d | 1,500 | 7.50 | 1 | 200 | 9 | 2,333 | D | | | | | | | | 1 | 2 | 0 | -6 | 18 | -2 | -15 |
7/30/04 17:16 | 7/28/04 | AUXL | Health | Drug | Pharmaceutical Preparations | Scp Private Equity Partners II LP | PA | T | | P.d | 375 | 7.50 | 1 | 50 | 2 | 3,043 | D | | | | | | | | 2 | 0 | 0 | -6 | 20 | 0 | -15 |
7/30/04 16:55 | 7/28/04 | AUXL | Health | Drug | Pharmaceutical Preparations | Churchill Winston J | PA | DT | | P.d | 375 | 7.50 | 1 | 50 | 2 | 3,272 | I | | | | | | | | 2 | 0 | 0 | -6 | 20 | 0 | -15 |
7/30/04 16:55 | 7/28/04 | AUXL | Health | Drug | Pharmaceutical Preparations | Chambon Philippe | NY | DT | | P.d | 1,500 | 7.50 | 1 | 200 | 10 | 2,301 | I | | | | | | | | 2 | 0 | 0 | -6 | 20 | 0 | -15 |
7/30/04 16:53 | 7/28/04 | AUXL | Health | Drug | Pharmaceutical Preparations | Henwood Geraldine | PA | DO | CEO | P | 4 | 7.50 | 1 | 1 | 0 | 294 | D | | | | | | | | 2 | 0 | 0 | -6 | 20 | 0 | -15 |
7/30/04 16:53 | 7/28/04 | AUXL | Health | Drug | Pharmaceutical Preparations | Lansing Cornelius H II | PA | O | CFO,EVP | P | 4 | 7.50 | 1 | 1 | 13 | 5 | D | | | | | | | | 2 | 0 | 0 | -6 | 20 | 0 | -15 |
7/30/04 16:52 | 7/28/04 | AUXL | Health | Drug | Pharmaceutical Preparations | Whitehead Robert S | PA | O | P,COO | P | 4 | 7.50 | 1 | 1 | New | 1 | D | | | | | | | | 2 | 0 | 0 | -6 | 20 | 0 | -15 |
7/30/04 16:14 | 7/28/04 | AUXL | Health | Drug | Pharmaceutical Preparations | Soros Fund Management LLC | NY | T | | P.d | 375 | 7.50 | 1 | 50 | 2 | 3,265 | I | | | | | | | | 2 | 0 | 0 | -6 | 20 | 0 | -15 |
7/30/04 16:08 | 7/28/04 | AUXL | Health | Drug | Pharmaceutical Preparations | Perseus Soros Biopharmaceutical Fund LP | NY | T | | P.d | 375 | 7.50 | 1 | 50 | 2 | 3,265 | D | | | | | | | | 2 | 0 | 0 | -6 | 20 | 0 | -15 |
7/30/04 16:05 | 7/28/04 | AUXL | Health | Drug | Pharmaceutical Preparations | Pearl Frank H | DC | T | | P.d | 375 | 7.50 | 1 | 50 | 2 | 3,265 | I | | | | | | | | 2 | 0 | 0 | -6 | 20 | 0 | -15 |